ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
56,968.98
-5.99%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.9625
0.15%
Brent Oil
85.265
-0.73%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) ニュース

AVDL Avadel Pharmaceuticals PLC

18.16
0.00 (0.00%)
プレマーケット
最終更新日： 17:00:01
15分遅延
名称 銘柄コード 市場 種別
Avadel Pharmaceuticals PLC AVDL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 18.16 17:00:01
始値 安値 高値 終値 前日終値
18.16
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0121:00GLOBEAvadel Pharmaceuticals to Present at the 23rd Annual Needham..
2024/3/0522:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
2024/3/0505:51EDGAR2Form 8-K - Current report
2024/3/0505:37GLOBEAvadel Pharmaceuticals Issues Statement On Patent Litigation
2024/3/0420:35EDGAR2Form 8-K - Current report
2024/3/0420:30GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
2024/3/0420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0420:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2622:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
2024/2/1421:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1407:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1323:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1222:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0722:00GLOBEAvadel Pharmaceuticals to Present at the Oppenheimer 34th..
2024/1/1706:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0821:20EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBEAvadel Pharmaceuticals Announces Strong LUMRYZ Launch..
2023/12/3006:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2904:54EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0823:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:09EDGAR2Form 8-K - Current report
2023/11/0821:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
2023/11/0722:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
2023/10/3021:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
2023/10/2021:00GLOBEAvadel Pharmaceuticals Announces Data Supporting Clinical..
2023/10/0521:00GLOBEAvadel Pharmaceuticals to Present at the Jefferies Biotech..
2023/9/0210:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0210:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3121:00GLOBEAvadel Pharmaceuticals to Present at Upcoming Investor..
2023/8/1605:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1506:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1205:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1204:50EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1107:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0922:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0920:37EDGAR2Form 8-K - Current report
2023/8/0920:00GLOBEAvadel Pharmaceuticals Provides Corporate Update and Reports..
2023/8/0405:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:15EDGAR2Form 8-K - Current report
2023/8/0405:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
2023/8/0320:30EDGAR2Form 8-K - Current report
2023/8/0221:00GLOBEAvadel Pharmaceuticals to Provide a Corporate Update and..
2023/7/2105:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..
2023/7/0705:05GLOBEAvadel Announces Grant of Inducement Awards Under Nasdaq..

最近閲覧した銘柄

NASDAQ
AVDL
Avadel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有